video

Information on health responses to the use of new psychoactive substances (NPS) is emerging but, in many cases, remains anecdotal. To mark World Drugs Day 2016 on 26 June, we will be...

With the Internet playing such a significant role in EU citizens' lives, especially among young people, it is not surprising that it is increasingly being recognised as a plausible vehicle for delivering...

While cocaine remains the most commonly used illicit stimulant in Europe, challenges still exist around the provision of treatment to users.  

Drug overdose continues to be the main cause of death among problem drug users and heroin or its metabolites are present in the majority of reported fatal overdoses. Naloxone is a lifesaving...

Benzodiazepines are a widely prescribed group of medicines with a range of clinical uses, including the treatment of anxiety and insomnia and the management of alcohol withdrawal. For a number of reasons...

Supervised drug consumption facilities, where illicit drugs can be used under the supervision of trained staff, have been operating in Europe for the last three decades. These facilities primarily aim to reduce...

The use of substitution drugs for the treatment of heroin dependence represents a key evidence-based response to heroin problems in Europe. The diversion of these medicines to non-medical use and sale on...

Drug use problems are often associated with health harms. Infectious diseases such as HIV/AIDS and hepatitis C, have clear links to drug use, but there are also links between drug use and...

The last decade has seen the emergence of new internet technologies that have acted as important facilitators of online drug markets. This upcoming EMCDDA publication aims to unravel some of the complexities...

What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with...